Security key
464288836
- Type / Class
- Equity / U.S. PHARMA ETF
- Total 13F shares
- 599,609
- Share change
- -451,241
- Total reported value
- $96,007,160
- Put/Call ratio
- 192%
- Price per share
- $160.11
- Number of holders
- 91
- Value change
- -$71,298,776
- Number of buys
- 35
- Number of sells
- 31
Report period
Q4 2019
Institutions
91
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 464288836
Recent filing periods:
Top shareholders of IHE - ISHARES TR - U.S. PHARMA ETF (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2019
As of 31 Dec 2019,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
599,609 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, ROYAL BANK OF CANADA, Fisher Asset Management, LLC, BROWN ADVISORY INC, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, MURPHY CAPITAL MANAGEMENT INC, COMMONWEALTH EQUITY SERVICES, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
91
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
82
Q4 2019 holders
91
Holder diff
9
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.